V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 220021188 | 220005208 | null | null | Curative (C) | 2017-12-16 | 2017-12-16 | Nilotinib | N | N | 220020414 | NILOTINIB |
| 220021189 | 220005219 | 1.73 | 162 | Curative (C) | 2017-02-08 | 2017-02-08 | Cytarabine High Dose | null | N | 220020435 | CYTARABINE HIGH DOSE |
| 220021190 | 220005232 | 1.73 | 85.5 | Curative (C) | 2015-09-22 | 2015-12-02 | Cytarabine High Dose | N | N | 220020450 | CYTARABINE HIGH DOSE |
| 220021192 | 220005251 | 1.71 | 73.2 | Curative (C) | 2018-05-30 | 2018-05-30 | Cytarabine High Dose | N | N | 220020473 | CYTARABINE HIGH DOSE |
| 220021193 | 220005262 | 0 | 0 | Curative (C) | null | 2014-10-15 | Nilotinib | 02 | N | 220020487 | NILOTINIB |
| 220021194 | 220005269 | 0 | 55.3 | Not known (9) | 2018-10-12 | 2018-12-17 | Nilotinib | N | N | 220020497 | NILOTINIB |
| 220021196 | 220016999 | null | 60 | Palliative (P) | 2016-01-10 | 2016-06-12 | AML17 TRIAL | null | null | 220020503 | AML17 TRIAL |
| 220021197 | 220005295 | 1.63 | 38 | Curative (C) | 2018-12-03 | 2018-12-09 | AML17 TRIAL | 01 | null | 220020551 | AML17 TRIAL |
| 220021198 | 220005306 | 1.57 | 57 | Curative (C) | 2017-04-30 | 2017-05-15 | FLAG + Idarubicin | 02 | N | 220020576 | FLAG + IDARUBICIN |
| 220021199 | 220005315 | null | 75.5 | Curative (C) | 2014-02-01 | 2014-02-01 | AML17 TRIAL | N | N | 220020591 | AML17 TRIAL |
| 220021200 | 220005326 | 1.81 | 103.4 | Curative (C) | 2018-12-20 | 2019-03-12 | FLAG + Idarubicin | N | N | 220020625 | FLAG + IDARUBICIN |
| 220021201 | 220005331 | 1.52 | 79.399 | null | 2013-10-26 | 2013-10-26 | AML17 TRIAL | N | null | 220020646 | AML17 TRIAL |
| 220021202 | 220012808 | 1.73 | 58.4 | Curative (C) | 2016-11-19 | 2017-12-15 | AML17 TRIAL | N | null | 220020649 | AML17 TRIAL |
| 220021203 | 220005339 | 1.68 | 57.4 | Curative (C) | 2014-07-04 | 2014-07-11 | AML17 TRIAL | N | N | 220020654 | AML17 TRIAL |
| 220021204 | 220017027 | 1.7 | 75.199 | Curative (C) | 2018-08-12 | 2019-03-16 | AML17 TRIAL | 2 | N | 220020673 | AML17 TRIAL |
| 220021205 | 220005360 | 1.71 | 105.8 | null | 1970-10-15 | 2015-08-20 | AML17 TRIAL | Y | N | 220020676 | AML17 TRIAL |
| 220021206 | 220012827 | 1.6 | 50.6 | Curative (C) | 2020-03-12 | 2020-03-12 | AML17 TRIAL | Y | N | 220020695 | AML17 TRIAL |
| 220021207 | 220005388 | 1.87 | 66.7 | Curative (C) | null | 2017-07-08 | AML Interim Guidelines FLAG-Ida | Y | Y | 220020746 | FLAG + IDARUBICIN |
| 220021208 | 220005412 | null | 84.8 | Disease modification (D) | 2018-01-13 | 2018-04-04 | FLAG + Idarubicin | 01 | N | 220020794 | FLAG + IDARUBICIN |
| 220021210 | 220005431 | 1.73 | 116 | Adjuvant (A) | 2016-08-12 | 2016-10-11 | AML17 TRIAL | Y | N | 220020879 | AML17 TRIAL |
| 220021211 | 220005435 | 1.84 | 125 | Curative (C) | 2018-08-05 | 2018-08-06 | FLAG + Idarubicin | 02 | N | 220020898 | FLAG + IDARUBICIN |
| 220021212 | 220017059 | 1.61 | null | Curative (C) | 2018-01-08 | 2018-01-08 | FLAG + Idarubicin | N | N | 220020962 | FLAG + IDARUBICIN |
| 220021213 | 220005457 | 1.65 | 80 | Curative (C) | 2016-01-15 | 2016-01-17 | FLAG + Idarubicin | N | N | 220020977 | FLAG + IDARUBICIN |
| 220021214 | 220005463 | 1.68 | 79.5 | Curative (C) | 2017-08-08 | 2017-09-10 | FLAG + Idarubicin | null | N | 220020990 | FLAG + IDARUBICIN |
| 220021215 | 220005490 | 1.77 | 69.3 | Curative (C) | 2013-04-17 | 2013-05-11 | AML17 TRIAL | 2 | null | 220021082 | AML17 TRIAL |
| 220021217 | 220005510 | 1.6 | 89.4 | Palliative (P) | 2018-11-22 | 2019-03-18 | AML17 TRIAL | 1 | N | 220021137 | AML17 TRIAL |
| 220021218 | 220005517 | 1.67 | null | Disease modification (D) | 2017-07-31 | 2017-08-07 | AML17 TRIAL | N | N | 220021149 | AML17 TRIAL |
| 220021219 | 220005522 | 1.7 | 86.8 | Curative (C) | 2018-06-10 | 2018-06-16 | FLAG + Idarubicin | N | N | 220021161 | FLAG + IDARUBICIN |
| 220021220 | 220005532 | 1.66 | 80 | Curative (C) | 2014-03-24 | 2014-03-24 | AML17 TRIAL | Y | N | 220021175 | AML17 TRIAL |
| 220021221 | 220012924 | 1.78 | 103.4 | Curative (C) | 1536-01-27 | 1536-01-27 | FLAG + Idarubicin | 1 | N | 220021255 | FLAG + IDARUBICIN |
| 220021222 | 220020688 | 1.78 | null | Curative (C) | 2015-03-15 | 2015-08-21 | FLAG + Idarubicin | N | N | 220021289 | FLAG + IDARUBICIN |
| 220021223 | 220005582 | 1.77 | 87.9 | Palliative (P) | 2018-04-26 | 2018-04-26 | FLAG + Idarubicin | 01 | N | 220021341 | FLAG + IDARUBICIN |
| 220021224 | 220005589 | 1.88 | 79 | Curative (C) | 2017-07-25 | 2017-10-07 | AML17 TRIAL | N | N | 220021359 | AML17 TRIAL |
| 220021225 | 220005602 | 1.66 | 74.2 | Curative (C) | 2018-01-02 | 2018-02-17 | AML17 TRIAL | N | N | 220021394 | AML17 TRIAL |
| 220021226 | 220005607 | 1.73 | 73.6 | Curative (C) | 2017-01-17 | 2017-01-17 | FLAG + Idarubicin | 01 | N | 220021411 | FLAG + IDARUBICIN |
| 220021227 | 220005621 | 1.77 | 84.3 | Curative (C) | 2015-10-29 | 2016-01-11 | AML17 TRIAL | N | N | 220021453 | AML17 TRIAL |
| 220021228 | 220005634 | 1.52 | 75.199 | Palliative (P) | 2019-03-12 | 2019-04-30 | AML17 TRIAL | N | N | 220021470 | AML17 TRIAL |
| 220021229 | 220005645 | 1.85 | 125 | Curative (C) | 2017-10-30 | 2018-02-09 | FLAG + Idarubicin | N | N | 220021483 | FLAG + IDARUBICIN |
| 220021230 | 220012980 | 1.57 | 69.9 | Palliative (P) | 2018-08-14 | 2018-08-14 | AML17 TRIAL | N | N | 220021572 | AML17 TRIAL |
| 220021232 | 220005712 | 1.55 | 75 | Disease modification (D) | 2018-05-02 | 2018-05-30 | AML17 TRIAL | Y | Y | 220021673 | AML17 TRIAL |
| 220021233 | 220005717 | 1.64 | 64 | Disease modification (D) | 2017-08-05 | 2017-08-06 | FLAG + Idarubicin | Y | null | 220021690 | FLAG + IDARUBICIN |
| 220021234 | 220005722 | null | null | Palliative (P) | 2016-06-21 | 2016-06-24 | FLAG + Idarubicin | 02 | N | 220021705 | FLAG + IDARUBICIN |
| 220021235 | 220005722 | 1.7 | 62.4 | null | 2018-11-04 | 2018-11-19 | AML17 TRIAL | N | N | 220021705 | AML17 TRIAL |
| 220021236 | 220005726 | null | 90.8 | Curative (C) | 2018-11-25 | 2018-11-27 | AML17 TRIAL | 1 | N | 220021721 | AML17 TRIAL |
| 220021237 | 220005731 | 1.62 | 91.6 | Curative (C) | 2016-03-31 | 2016-04-08 | FLAG + Idarubicin | N | N | 220021727 | FLAG + IDARUBICIN |
| 220021238 | 220005745 | 1.75 | 56.5 | Curative (C) | 2015-07-27 | 2015-09-06 | FLAG + Idarubicin | N | N | 220021755 | FLAG + IDARUBICIN |
| 220021239 | 220005760 | 1.77 | 116.8 | Curative (C) | 2017-07-07 | 2017-07-07 | FLAG + Idarubicin | 02 | null | 220021789 | FLAG + IDARUBICIN |
| 220021240 | 220005764 | 1.67 | 80.7 | Disease modification (D) | 2014-12-14 | 2015-02-03 | AML17 TRIAL | 01 | N | 220021792 | AML17 TRIAL |
| 220021241 | 220005772 | 1.73 | 73.999 | Curative (C) | 2015-09-22 | 2015-11-03 | AML17 TRIAL | null | N | 220021810 | AML17 TRIAL |
| 220021243 | 220005792 | null | 65.1 | Curative (C) | 2013-07-25 | 2013-07-25 | FLAG + Idarubicin | N | N | 220021861 | FLAG + IDARUBICIN |